tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Buy Rating for Janux Therapeutics Inc: Promising Oncology Innovations and Strategic Advancements
PremiumRatingsBuy Rating for Janux Therapeutics Inc: Promising Oncology Innovations and Strategic Advancements
20d ago
Janux Therapeutics resumed with a Buy at Stifel
Premium
The Fly
Janux Therapeutics resumed with a Buy at Stifel
20d ago
Janux Therapeutics initiated with a Buy at Guggenheim
Premium
The Fly
Janux Therapeutics initiated with a Buy at Guggenheim
26d ago
Promising Future for Janux Therapeutics: Buy Rating Backed by Strong Clinical Profile and Strategic Trials
PremiumRatingsPromising Future for Janux Therapeutics: Buy Rating Backed by Strong Clinical Profile and Strategic Trials
2M ago
Promising Developments and Strategic Expansion at Janux Therapeutics: Analyst Sets $70 Price Target
Premium
Ratings
Promising Developments and Strategic Expansion at Janux Therapeutics: Analyst Sets $70 Price Target
2M ago
Buy Rating for Janux Therapeutics Driven by Promising Pipeline and Strong Financial Position
Premium
Ratings
Buy Rating for Janux Therapeutics Driven by Promising Pipeline and Strong Financial Position
2M ago
Janux Therapeutics reports Q2 EPS (55c), consensus (47c)
PremiumThe FlyJanux Therapeutics reports Q2 EPS (55c), consensus (47c)
2M ago
Janux Therapeutics reaches clinical milestone in Merck TRACTr collaboration
Premium
The Fly
Janux Therapeutics reaches clinical milestone in Merck TRACTr collaboration
2M ago
Janux Therapeutics: Strategic Innovations and Robust Pipeline Drive Buy Rating
Premium
Ratings
Janux Therapeutics: Strategic Innovations and Robust Pipeline Drive Buy Rating
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100